Evidence map›Paper›PMID 34907471›Full record

ArticleHuman genetics2022

Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males.

Hans-Jürgen Kreienkamp, Matias Wagner, Heike Weigand, Allyn McConkie-Rossell, Marie McDonald, Boris Keren, Cyril Mignot, Julie Gauthier, Jean-François Soucy, Jacques L Michaud and 9 more

Open access · hybridAbstract readCase ReportsTwin Study
In one paragraph

Article in Human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. RNArchitects: how hnRNPs shape neuronal landscapes.Brain : a journal of neurology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. The HNRNPF/H RNA binding proteins and disease.Wiley interdisciplinary reviews. RNA
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Hans-Jürgen KreienkampInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Matias WagnerInstitute of Human Genetics, Technical University of Munich, Munich, Germany.
Heike WeigandDepartment of Pediatric Neurology, Developmental Medicine and Social Pediatrics, Dr. von Hauner's Children's Hospital, University of Munich, Munich, Germany.
Allyn McConkie-RossellDivision of Medical Genetics, Department of Pediatrics, Duke University, Durham, USA.
Marie McDonaldDivision of Medical Genetics, Department of Pediatrics, Duke University, Durham, USA.
Boris KerenDépartement de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Cyril MignotDépartement de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Julie GauthierMolecular Diagnostic Laboratory, CHU Sainte-Justine, Montreal, QC, Canada.
Jean-François SoucyMolecular Diagnostic Laboratory, CHU Sainte-Justine, Montreal, QC, Canada.
Jacques L MichaudMolecular Diagnostic Laboratory, CHU Sainte-Justine, Montreal, QC, Canada.
Meghan DumasDivision of Genetic, Department of Pediatrics, The Barbara Bush Children's Hospital, Maine Medical Center, Portland, ME, USA.
Rosemarie SmithDivision of Genetic, Department of Pediatrics, The Barbara Bush Children's Hospital, Maine Medical Center, Portland, ME, USA.
Ulrike LöbelDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Maja HempelInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Christian KubischInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Jonas DeneckeDepartment of Pediatrics, University Medical Center Eppendorf, Hamburg, Germany.
Philippe M CampeauDepartment of Pediatrics, CHU Sainte-Justine and University of Montreal, Montreal, Canada.
Jennifer M BainDivision of Child Neurology, Department of Neurology, Columbia University Irving Medical Center, New York, USA.
Davor LesselInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. d.lessel@uke.de.ORCID http://orcid.org/0000-0003-4496-244X
Universität Hamburg · DECentre Hospitalier Universitaire Sainte-Justine · CADuke University · USMaine Medical Center · USSorbonne Université · FRColumbia University Irving Medical Center · USLudwig-Maximilians-Universität München · DETechnical University of Munich · DE

Funding

Deutsche Forschungsgemeinschaft Kr1321/11-1Deutsche Forschungsgemeinschaft LE4223/3-1
6 · The paper itself

Abstract

Bain type of X-linked syndromic intellectual developmental disorder, caused by pathogenic missense variants in HRNRPH2, was initially described in six female individuals affected by moderate-to-severe neurodevelopmental delay. Although it was initially postulated that the condition would not be compatible with life in males, several affected male individuals harboring pathogenic variants in HNRNPH2 have since been documented. However, functional in-vitro analyses of identified variants have not been performed and, therefore, possible genotype-phenotype correlations remain elusive. Here, we present eight male individuals, including a pair of monozygotic twins, harboring pathogenic or likely pathogenic HNRNPH2 variants. Notably, we present the first individuals harboring nonsense or frameshift variants who, similarly to an individual harboring a de novo p.(Arg29Cys) variant within the first quasi-RNA-recognition motif (qRRM), displayed mild developmental delay, and developed mostly autistic features and/or psychiatric co-morbidities. Additionally, we present two individuals harboring a recurrent de novo p.(Arg114Trp), within the second qRRM, who had a severe neurodevelopmental delay with seizures. Functional characterization of the three most common HNRNPH2 missense variants revealed dysfunctional nucleocytoplasmic shuttling of proteins harboring the p.(Arg206Gln) and p.(Pro209Leu) variants, located within the nuclear localization signal, whereas proteins with p.(Arg114Trp) showed reduced interaction with members of the large assembly of splicing regulators (LASR). Moreover, RNA-sequencing of primary fibroblasts of the individual harboring the p.(Arg114Trp) revealed substantial alterations in the regulation of alternative splicing along with global transcriptome changes. Thus, we further expand the clinical and variant spectrum in HNRNPH2-associated disease in males and provide novel molecular insights suggesting the disorder to be a spliceopathy on the molecular level.

Indexed as

MutationAdolescentAlternative SplicingAmino Acid SubstitutionBrainChildChild, PreschoolChromosomes, Human, XCodon, NonsenseDiseases in TwinsFemaleFrameshift MutationGenetic Association StudiesGenetic VariationHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansCodon, NonsenseHeterogeneous-Nuclear Ribonucleoprotein Group F-HHNRNPH2 protein, human

Identifiers

PMID34907471
PMCPMC8807443
OpenAlexW4200506034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.